MedTrace Logo

Enhancing Protection Against Vector-borne Diseases in Forcibly Displaced Communities: Evaluating the Efficacy of Spatial Repellents for Cutaneous Leishmaniasis Control in North-East Syria

NCT06917040 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 18404

Last updated 2025-04-08

No results posted yet for this study

Summary

The aim of this study is to determine the efficacy of Mosquito Shield (spatial repellent) in reducing cutaneous leishmaniasis case incidence among internally displaced persons and sandfly density in temporary shelters and camp settings in Ar-Raqqa governorate, North-East Syria.

Conditions

  • Leishmaniasis, Cutaneous
  • Vector Borne Diseases

Interventions

DEVICE

Spatial repellant emanator

Spatial emanator with an active ingredient Transfluthrin (C15H12Cl2F4O2, 110mg, EPA registered number 432-1588).

Sponsors & Collaborators

  • University of Nevada, Las Vegas

    collaborator OTHER

  • Hacettepe University

    collaborator OTHER

  • The Mentor Initiative

    lead OTHER

Principal Investigators

  • Richard J Allan, PhD · The Mentor Initiative

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2022-04-01
Completion
2022-04-01

Countries

  • Syria

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06917040 on ClinicalTrials.gov